Isosorbide

Isosorbide Overview

Isosorbide is a bicyclic, di-anhydro sugar alcohol derivative of D-sorbitol. Chemically, it belongs to the class of organic compounds known as isosorbides within the furofurans class of organoheterocyclic compounds. Structurally, it consists of two fused tetrahydrofuran (oxolane) rings bearing two secondary hydroxyl groups at the C-2 and C-5 positions with a cis-fused ring junction, possessing a molecular weight of 146.14 g/mol.

What Is Isosorbide and How Does It Work?

Isosorbide acts primarily through rapid systemic absorption to elevate plasma osmolality relative to ocular fluids, creating a steep intravascular-to-vitreous osmotic gradient that draws water out of the vitreous body into retinal/choroidal capillaries, driving vitreous volume shrinkage, anterior chamber deepening, and rapid intraocular pressure reduction during acute glaucoma attacks.

Is Isosorbide FDA Approved?

Isosorbide (specifically formulated as a 45% oral solution under the trade name Ismotic, NDA 017063) received its initial New Drug Application approval from the U.S. Food and Drug Administration (FDA) on January 30, 1974, as a prescription hyperosmotic agent for rapid intraocular pressure reduction in acute angle-closure glaucoma and pre-operative ocular dehydration. Following commercial discontinuation by the sponsor (Alcon Research, LLC), the FDA formally withdrew approval of NDA 017063 effective February 7, 2020 (Federal Register 85 FR 915) upon voluntary request by the applicant. While unsubstituted elemental isosorbide solution is withdrawn, its organic nitrate ester derivatives remain separately approved by the FDA for antianginal cardiovascular indications.

What Was/Is Isosorbide Used For?

• Emergency reduction of severely elevated intraocular pressure (IOP) during acute primary angle-closure glaucoma attacks.
• Pre-operative hyperosmotic ocular dehydration prior to intraocular surgical procedures (cataract extraction, trabeculectomy, keratoplasty) to prevent vitreous prolapse and intraoperative flat anterior chamber.
• Short-term management of secondary glaucoma or malignant (aqueous misdirection) glaucoma refractory to topical ocular hypotensives.
• Chemical precursor base for organic nitrate antianginal pharmaceuticals (Isosorbide Mononitrate and Isosorbide Dinitrate).

Before Taking Isosorbide: Contraindications & Precautions

Do not administer Isosorbide to patients with a known severe hypersensitivity to isosorbide, dianhydrohexitols, or formulation excipients. It is strictly contraindicated in patients with well-established anuria secondary to severe renal disease, severe cardiac decompensation or acute pulmonary edema, severe dehydration, or active intracranial hemorrhage, as rapid expansion of intravascular volume can precipitate acute heart failure or worsen cerebral edema. Exercise extreme caution in diabetic patients; oral Isosorbide solutions are heavily sweetened with flavorings and can alter glycemic stability.

Who Should Not Take Isosorbide?

• Individuals with well-established anuria or end-stage renal failure.
• Patients with severe, uncompensated congestive heart failure or acute pulmonary edema.
• Patients with severe systemic dehydration or hyperosmolar states.
• Patients with active intracranial hemorrhage.
• Individuals with known severe hypersensitivity to Isosorbide or polyols.

Isosorbide, Pregnancy & Safety

Systemic oral administration of hyperosmotic Isosorbide causes marked intravascular fluid shifts and maternal-fetal osmotic gradient alterations. Controlled clinical trials evaluating Isosorbide in pregnant women are lacking. It is classified as Pregnancy Category C. Isosorbide should be administered during pregnancy only if the acute emergency necessity (such as an acute glaucoma attack threatening vision) clearly justifies potential fetal risks.

Tell Your Doctor Before Taking Isosorbide

Inform your ophthalmologist, emergency physician, or cardiologist if you have a history of heart failure, kidney disease, diabetes, dehydration, or stroke, or if you are taking diuretics, blood pressure medications, or organic nitrates.

Isosorbide Dosage & Administration

Formulated as a concentrated oral solution (45% w/v [450 mg/mL] isosorbide; formerly Ismotic).

Isosorbide dosing requires precise weight-based calculation for acute emergency hyperosmotic therapy.

Standard Isosorbide Dosing

• Acute Intraocular Pressure Reduction Dosing (Adults): Administered as 1.0 g/kg to 2.0 g/kg body weight (approx. 2.2 mL/kg to 4.4 mL/kg of 45% solution) orally as a single dose, given 1 to 3 hours prior to surgery or during acute glaucoma attacks.
• Standard Adult Initial Single Dose Range: Typically 1.5 g/kg body weight (approx. 100 mL to 150 mL of 45% solution) consumed over 5 to 10 minutes.

How Was/Is Isosorbide Administered

• Administer orally over ice or chilled; pouring the concentrated, viscous solution over cracked ice significantly improves palatability and reduces nausea.
• Patients should remain seated or recumbent during and immediately following administration to prevent orthostatic lightheadedness.

Isosorbide Clinical Efficacy & Research

In clinical ophthalmology and emergency medicine research, Isosorbide is recognized as a potent oral hyperosmotic agent. Clinical trials evaluating oral Isosorbide 45% (Ismotic) at doses of 1.5 g/kg in patients with acute angle-closure glaucoma or ocular hypertension demonstrate a rapid mean IOP reduction of 15 to 30 mmHg (30% to 50% baseline reduction) within 30 to 60 minutes post-ingestion, with peak hypotensive effect occurring at 1 to 2 hours and duration of action lasting 4 to 6 hours. Comparative clinical studies establish that oral Isosorbide achieves equivalent intraocular pressure lowering to oral glycerol (glycerin) and intravenous mannitol (20%).

Isosorbide Side Effects & Safety Profile

Isosorbide exhibits a predictable safety profile governed by its hyperosmotic mechanism. Safety hazards stem primarily from intravascular fluid expansion followed by systemic dehydration and thirst.

Adverse effects are predominantly gastrointestinal, neurological, and fluid/electrolyte related.

Common Isosorbide Side Effects

• Gastrointestinal (10% to 25% incidence): Nausea, vomiting, eructation, gastric fullness, and thirst.
• Neurological (10% to 20% incidence): Headache, dizziness, lightheadedness, vertigo, and lethargy.

Serious Isosorbide Adverse Events

• Acute Fluid Overload & Congestive Heart Failure: Initial rapid intravascular fluid expansion pulling interstitial water into circulation, precipitating acute pulmonary edema or heart failure exacerbation in patients with compromised cardiac function.
• Severe Dehydration & Hypernatremia: Excessive osmotic diuresis leading to profound free water loss, cellular dehydration, confusion, and hypernatremia.
• Electrolyte Imbalance: Hypokalemia and hyponatremia secondary to brisk osmotic diuresis.
• Syncope & Orthostatic Hypotension: Hypovolemia following osmotic diuresis causing postural hypotension and syncope.

Managing Isosorbide Side Effects

Chill the oral solution over ice to prevent nausea and vomiting. Monitor pulse, blood pressure, and lung sounds for signs of fluid overload during the first 2 hours. Ensure adequate oral fluid replacement once intraocular pressure is controlled to prevent severe dehydration.

Isosorbide Drug Interactions & What to Avoid

Isosorbide displays important pharmacodynamic interactions with systemic diuretics, antihypertensives, and antidiabetic agents.

Co-administration with specific drug classes accelerates fluid shifts or blood pressure lowering.

Isosorbide Drug-Drug Interactions

• Loop Diuretics (Furosemide, Bumetanide) & Thiazides: Synergistic osmotic diuresis; co-administration dramatically accelerates urinary volume loss, predisposing to severe dehydration, hypokalemia, and hypotension.
• Antihypertensive Agents (Lisinopril, Amlodipine, Metoprolol): Additive blood-pressure-lowering effect following osmotic diuresis, increasing orthostatic hypotension risk.
• Insulin & Oral Antidiabetic Drugs: Unlike glycerol, elemental Isosorbide does not raise blood glucose, but fluid shifts and co-formulated flavorings may require monitoring of blood glucose in diabetic patients.
• Organic Nitrates (Isosorbide Mononitrate / Dinitrate) & PDE5 Inhibitors (Sildenafil): Note: Unsubstituted Isosorbide does not act as a nitrate vasodilator; however, esterified nitrate forms (ISMN/ISDN) combined with PDE5 inhibitors trigger catastrophic hypotension.

Isosorbide, Food & Alcohol

Administering over cracked ice improves palatability. Systemic alcohol consumption exacerbates central nervous system depression, dizziness, and dehydration following osmotic diuresis.

Isosorbide: Missed Dose, Overdose & Storage

Proper handling of Isosorbide involves single-dose or short-term acute administration under medical supervision. Overdose leads to severe dehydration and electrolyte collapse.

Adherence to proper storage parameters prevents crystallization and solution degradation.

Missed Dose of Isosorbide

Not applicable. Isosorbide is administered as an acute emergency or pre-operative single dose by healthcare professionals in clinical settings.

Isosorbide Overdose & Emergency

Massive acute overdose of oral Isosorbide causes severe osmotic diuresis, profuse vomiting, marked systemic dehydration, hypernatremia, severe headache, confusion, hypotension, and circulatory collapse. Emergency management includes immediate fluid resuscitation with 0.45% or 0.9% Sodium Chloride IV fluids, monitoring serum osmolality and electrolytes, and correcting hypernatremia slowly to prevent cerebral edema.

How to Store Isosorbide

Store Isosorbide 45% oral solution at controlled room temperature between 15°C and 30°C (59°F to 86°F). Avoid exposure to extreme cold or freezing, which can cause solute crystallization. Keep container tightly closed. Keep out of reach of children.

Isosorbide Patient Management & Monitoring

Clinical oversight for patients receiving Isosorbide focuses on measuring intraocular pressure, monitoring serum osmolality, and evaluating fluid balance and cardiac status.

Regular clinical tracking ensures rapid IOP reduction without cardiovascular or renal decompensation.

Tests Before Starting Isosorbide

Baseline intraocular pressure (IOP) measurement via Goldmann applanation tonometry; baseline serum electrolytes (sodium, potassium), blood urea nitrogen (BUN), and serum creatinine; baseline cardiovascular examination (heart rate, blood pressure, lung auscultation) to rule out heart failure.

Monitoring During Isosorbide Treatment

Measuring IOP at 30 minutes, 60 minutes, and 2 hours post-administration; monitoring urine output and signs of systemic dehydration; re-evaluating serum electrolytes if repeat doses are required.

Isosorbide Do’s and Don’ts

• Do sip the chilled Isosorbide solution over cracked ice to prevent stomach nausea.
• Do remain lying down or seated for at least 1 to 2 hours after taking the medication to prevent dizziness.
• Do inform your doctor immediately if you experience shortness of breath, chest tightness, or severe confusion.
• Do not attempt to drive or stand up quickly after taking Isosorbide.
• Do not take Isosorbide if you have severe kidney failure or active heart failure.
• Do not confuse oral Isosorbide with antianginal Isosorbide Mononitrate or Dinitrate tablets.

Frequently Asked Questions

References

• DrugBank Database – Isosorbide Clinical Profile (DB09401)
• Classyfire Database – Isosorbides / Furofurans Taxonomy Profile
• US Food and Drug Administration (FDA) – Ismotic (Isosorbide Oral Solution 45%) Prescribing Information

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.